A verdict has been found in the class action lawsuit filed against Cytodyne Technologies on behalf of consumers. The court has ordered the company to pay $12,536,820, the amount identified as "obtained by means of unlawful practice." The suit alleged that the companies advertisements for its ephedra-based Xenadrine RFA-1 diet products were deceptive. (May-30-03) [EMAIL LAW FIRM]
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
